Article Information
History
- April 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Meghan L. Rudd1,#a,
- Nancy F. Hansen1,
- Xiaolu Zhang1,#b,
- Mary Ellen Urick1,
- Suiyuan Zhang2,
- Maria J. Merino3,
- National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program4,
- James C. Mullikin1,
- Lawrence C. Brody5 and
- Daphne W. Bell1,*
- 1Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- 2Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- 3Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- 4NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Rockville, Maryland, United States of America
- 5Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America
- ↵*Corresponding author: Email: belldaph{at}mail.nih.gov (DWB)
Posted April 30, 2021.
KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas
